Winton Group LTD Edwards Lifesciences Corp Transaction History

Winton Group LTD

$1.35 Billion
Q4 2024

A detailed history of Winton Group LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Winton Group LTD holds 43,627 shares of EW stock, worth $3.09 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

43,627

Holding current value

$3.09 Million

% of portfolio

0.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$64.54 - $75.92 $2.82 Million - $3.31 Million	43,627 New	43,627 $3.23 Million
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $594,483 - $665,074	7,052 Added 42.64%	23,590 $2.18 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $1.2 Million - $1.58 Million	16,538 New	16,538 $1.58 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $615,378 - $713,040	-7,559 Reduced 47.29%	8,424 $794,000
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $1.19 Million - $1.35 Million	15,983 New	15,983 $1.32 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $1.54 Million - $1.9 Million	-14,515 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$102.91 - $122.75 $1.19 Million - $1.42 Million	11,605 Added 398.8%	14,515 $1.64 Million
Q2 2021 Aug 10, 2021	SELL	$83.84 - $104.76 $316,412 - $395,364	-3,774 Reduced 56.46%	2,910 $301,000
Q1 2021 Jul 21, 2021	BUY	$78.68 - $90.67 $21,086 - $24,299	268 Added 4.18%	6,684 $559,000
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $15.7 Million - $20 Million	-218,985 Reduced 97.15%	6,416 $585,000
Q3 2020 Oct 30, 2020	SELL	$67.19 - $87.44 $4.44 Million - $5.78 Million	-66,109 Reduced 22.68%	225,401 $18 Million
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $16.7 Million - $22.3 Million	289,757 Added 16529.21%	291,510 $20.1 Million
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $814,765 - $1.26 Million	-15,546 Reduced 89.87%	1,753 $331,000
Q4 2019 Feb 13, 2020	SELL	$71.7 - $82.09 $1.71 Million - $1.96 Million	-23,816 Reduced 57.93%	17,299 $4.04 Million
Q3 2019 Nov 08, 2019	BUY	$61.55 - $75.43 $2.18 Million - $2.67 Million	35,371 Added 615.79%	41,115 $9.04 Million
Q2 2019 Jul 08, 2019	BUY	$55.74 - $64.41 $93,253 - $107,757	1,673 Added 41.1%	5,744 $1.06 Million
Q1 2019 May 13, 2019	SELL	$47.89 - $64.05 $44,729 - $59,822	-934 Reduced 18.66%	4,071 $779,000
Q4 2018 Feb 05, 2019	BUY	$46.41 - $56.94 $510 - $626	11 Added 0.22%	5,005 $767,000
Q3 2018 Nov 02, 2018	SELL	$45.7 - $58.03 $135,866 - $172,523	-2,973 Reduced 37.32%	4,994 $0
Q2 2018 Aug 20, 2018	SELL	$42.45 - $51.3 $138,387 - $167,238	-3,260 Reduced 29.04%	7,967 $0
Q1 2018 May 21, 2018	BUY	$37.19 - $47.45 $88,251 - $112,598	2,373 Added 26.8%	11,227 $0
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $117,927 - $137,471	-3,490 Reduced 28.27%	8,854 $998,000
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $40,173 - $42,984	1,107 Added 9.85%	12,344 $1.35 Million
Q2 2017 Aug 17, 2017	BUY	N/A	11,237	11,237 $1.33 Million

Others Institutions Holding EW

# of Institutions

1,364

Shares Held

475M

Call Options Held

9.74M

Put Options Held

3.85M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account